Epidemiology, pathophysiology, and therapeutic targets in stable ischemic heart disease

(Cardiovascular Innovations and Applications) In the current issue of Cardiovascular Innovations and Applications, C. Richard Conti from the University of Florida Medical School, Gainesville, Fla., USA considers epidemiology, pathophysiology, and therapeutic targets in stable ischemic heart disease.